サンプル依頼リスト カート
  • English
  • Korean
表紙：抗ウイルス薬の世界市場：タイプ別、用途別、流通チャネル別、国別、地域別 - 産業分析、市場規模、市場シェア、予測（2023～2030年）
市場調査レポート
商品コード
1408902

抗ウイルス薬の世界市場：タイプ別、用途別、流通チャネル別、国別、地域別 - 産業分析、市場規模、市場シェア、予測（2023～2030年）

Antiviral Drugs Market, By Type, By Application, By Distribution Channel, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日: | 発行: AnalystView Market Insights | ページ情報: 英文 303 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=154.94円
抗ウイルス薬の世界市場：タイプ別、用途別、流通チャネル別、国別、地域別 - 産業分析、市場規模、市場シェア、予測（2023～2030年）
出版日: 2024年01月07日
発行: AnalystView Market Insights
ページ情報: 英文 303 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

世界の抗ウイルス薬の市場規模は、2022年に684億3,040万米ドルとなり、2023～2030年にかけてCAGR 2.1%で拡大すると予測されています。

抗ウイルス薬市場 - 市場力学

ウイルス性疾患の流行と抗ウイルス薬の市場開拓が市場需要を促進

予測期間中、ウイルス感染症に対する認知度の向上とさまざまな予防接種の利用可能性、ウイルス性疾患の有病率の上昇が、抗ウイルス薬のジェネリックバージョンの発売につながっており、市場の成長にプラスの影響を与えると予測されます。WHOは、全世界で3億2,500万人が肝炎に感染しており、そのうち約7,100万人がC型肝炎ウイルス（HCV）に慢性感染していると推定しています。さらに米国保健社会福祉省は、国内で85万人がB型肝炎に、240万人がC型肝炎に感染していると計算しています。したがって、患者数の増加に伴い、抗ウイルス薬の需要が国際的に高まることが予想されます。

抗ウイルス薬市場 - 主要洞察

  • 世界市場は予測期間（2023～2030年）において、年間CAGR 2.1%程度で成長すると予測されます。
  • タイプ別セグメンテーションでは、ウイルス治療におけるブランド治療薬の高い採用率により、2022年には合成ブランドセグメントが最大の市場シェアを示すと予測されます。
  • 用途別セグメンテーションでは、主に抗レトロウイルス治療薬の需要増加により、HIV治療薬が2022年の主要タイプでした。
  • 流通チャネル別セグメンテーションでは、主に入院治療のニーズにより、病院薬局が2022年の主要タイプでした。
  • 地域別では、技術的に高度な生産設備が利用可能であることから、北米が2022年の主要な収益源でした。

抗ウイルス薬市場 - セグメンテーション分析：

  • 抗ウイルス薬の世界市場は、タイプ、用途、流通チャネル、地域に基づいて区分されます。
  • タイプ別では、ブランド品とジェネリック医薬品の4つに分類されます。ブランド品が市場を独占しています。技術開発、新規治療薬の重視の高まりが市場成長に寄与するとみられます。
  • 市場は用途別に5つに分類されます（HIV、肝炎、ヘルペス、インフルエンザ、その他）。HIV分野は市場を独占しており、予測期間中もその優位性を維持するとみられます。抗ウイルス薬は、治療薬によるHIVウイルス感染症の治療において重要な役割を果たしています。
  • 市場は流通チャネルによって、病院薬局、小売薬局、オンライン薬局の3つに分類されます。病院薬局は市場を独占しており、予測期間中もその優位性を維持すると思われます。オンライン薬局は、オンラインeコマースの恩恵を受け、速いペースで牽引力を増しています。

抗ウイルス薬市場 - 地理的洞察

地域的には、この市場は北米、ラテンアメリカ、欧州、アジア太平洋、中東・アフリカの各地域に広がっています。これらの地域は、ビジネスを展開する国によってさらに分けられます。

抗ウイルス薬市場 - 競合情勢：

市場シェアを拡大するため、企業は製品ラインを拡大する目的で、合弁事業、合併、買収、臨床試験、戦略的合意などの戦略的イニシアティブに取り組んでいます。また、市場参入企業は、世界市場での地位を維持するため、食物アレルギー用製品のリリースや世界展開に注力しています。世界の抗ウイルス薬市場は、支持的なFDA、米国、政府との協力関係によってさらに影響を受けています。例えば、2021年12月、Merck社はRidgeback Biotherapeutics社と提携し、低～高COVID-19を治療するためのバックアップ用経口抗ウイルス薬molnupiravirのFDA承認を確立しました。

目次

第1章 抗ウイルス薬の市場概要

  • 調査範囲
  • 市場推定年数

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 抗ウイルス薬の主要な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 今後の市場動向

第4章 抗ウイルス薬の産業調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しのマッピング
  • 規制枠組みの分析

第5章 抗ウイルス薬市場：COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19後の影響分析

第6章 抗ウイルス薬の市場情勢

  • 抗ウイルス薬市場シェア分析、2022年
  • 内訳データ：主要メーカー別
    • 既存企業の分析
    • 新興企業の分析

第7章 抗ウイルス薬市場：タイプ別

  • 概要
    • セグメントシェア分析：タイプ別
    • ブランド
    • ジェネリック

第8章 抗ウイルス薬市場：用途別

  • 概要
    • セグメントシェア分析：用途別
    • HIV
    • 肝炎
    • ヘルペス
    • インフルエンザ
    • その他

第9章 抗ウイルス薬市場：流通チャネル別

  • 概要
    • セグメントシェア分析：流通チャネル別
    • 病院薬局
    • 小売薬局
    • オンライン薬局

第10章 抗ウイルス薬市場：地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋
    • 概要
    • アジア太平洋の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析：抗ウイルス薬業界

  • 競合ダッシュボード
  • 企業プロファイル
    • F. Hoffmann-La Roche Ltd.
    • GSK plc.
    • AbbVie, Inc.
    • Merck &Co., Inc.
    • Johnson &Johnson Services, Inc.
    • Bristol-Myers Squibb Company
    • Cipla Inc.
    • Ridgeback Biotherapeutics
    • Aurobindo Pharm
    • Dr. Reddy's Laboratories Ltd.
    • Zydus Pharmaceuticals
    • SIGA Technologies
    • Pfizer Inc.
    • NAVINTA LLC
    • Sun Pharma
    • その他

第12章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Antiviral Drugs Market: Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Type
  • TABLE Global Antiviral Drugs Market, by Type 2018-2030 (USD Million)
  • TABLE Antiviral Drugs Market: Application Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Antiviral Drugs Market, by Application 2018-2030 (USD Million)
  • TABLE Antiviral Drugs Market: Distribution Channel Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Distribution Channel
  • TABLE Global Antiviral Drugs Market, by Distribution Channel 2018-2030 (USD Million)
  • TABLE Antiviral Drugs Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Antiviral Drugs Market, by Region 2018-2030 (USD Million)
  • TABLE North America Antiviral Drugs Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Antiviral Drugs Market, by Type, 2018-2030 (USD Million)
  • TABLE North America Antiviral Drugs Market, by Application, 2018-2030 (USD Million)
  • TABLE North America Antiviral Drugs Market, by Distribution Channel, 2018-2030 (USD Million)
  • TABLE Europe Antiviral Drugs Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Antiviral Drugs Market, by Type, 2018-2030 (USD Million)
  • TABLE Europe Antiviral Drugs Market, by Application, 2018-2030 (USD Million)
  • TABLE Europe Antiviral Drugs Market, by Distribution Channel, 2018-2030 (USD Million)
  • TABLE Asia Pacific Antiviral Drugs Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Antiviral Drugs Market, by Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Antiviral Drugs Market, by Application, 2018-2030 (USD Million)
  • TABLE Asia Pacific Antiviral Drugs Market, by Distribution Channel, 2018-2030 (USD Million)
  • TABLE Latin America Antiviral Drugs Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Antiviral Drugs Market, by Type, 2018-2030 (USD Million)
  • TABLE Latin America Antiviral Drugs Market, by Application, 2018-2030 (USD Million)
  • TABLE Latin America Antiviral Drugs Market, by Distribution Channel, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Antiviral Drugs Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Antiviral Drugs Market, by Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Antiviral Drugs Market, by Application, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Antiviral Drugs Market, by Distribution Channel, 2018-2030 (USD Million)

List of Figures

  • FIGURE Antiviral Drugs Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Type segment market share analysis, 2022 & 2030
  • FIGURE Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Application segment market share analysis, 2022 & 2030
  • FIGURE Application segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Distribution Channel segment market share analysis, 2022 & 2030
  • FIGURE Distribution Channel segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022 & 2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Antiviral Drugs Market share and leading players, 2022
  • FIGURE Europe Antiviral Drugs Market share and leading players, 2022
  • FIGURE Asia Pacific Antiviral Drugs Market share and leading players, 2022
  • FIGURE Latin America Antiviral Drugs Market share and leading players, 2022
  • FIGURE Middle East and Africa Antiviral Drugs Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Antiviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Antiviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Antiviral Drugs Market share analysis by country, 2022
  • FIGURE Germany Antiviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Antiviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Antiviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Antiviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Antiviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Antiviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Antiviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Antiviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Antiviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Antiviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Antiviral Drugs Market share analysis by country, 2022
  • FIGURE India Antiviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Antiviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Antiviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Antiviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Antiviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Antiviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Antiviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Antiviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Antiviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Antiviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Antiviral Drugs Market share analysis by country, 2022
  • FIGURE Brazil Antiviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Antiviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Antiviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Antiviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Antiviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Antiviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Antiviral Drugs Market share analysis by country, 2022
  • FIGURE Saudi Arabia Antiviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Antiviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Antiviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Antiviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Antiviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Antiviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Antiviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
目次
Product Code: ANV2084

REPORT HIGHLIGHT

Antiviral Drugs Market size was valued at USD 68,430.4 Million in 2022, expanding at a CAGR of -2.1% from 2023 to 2030.

Antiviral drugs are prescriptions that work by preventing viruses from replicating within the cells that they infect. These medications either stop the virus from entering the host cell or disrupt essential enzymes or proteins needed for viral reproduction. They are designed to target certain viruses or virus species.

Antiviral Drugs Market- Market Dynamics

Increasing prevalence of viral disorders and development in antiviral medicines is to propel market demand

Over the forecast period, rising awareness and availability of different vaccinations for viral infections and the rising prevalence of viral diseases, which has led to the launch of generic versions of antiviral medications, are projected to positively affect the market's growth. The WHO estimates that 325 million individuals worldwide have hepatitis infection, and of those, about 71 million have chronic infection with the Hepatitis C virus (HCV). Furthermore, the U.S. Department of Health and Human Services calculated that 850,000 people in the nation are infected with hepatitis B, and 2.4 million people with hepatitis C. Therefore, it is expected that the demand for antiviral medications will rise internationally as the number of patients grows.

Antiviral Drugs Market- Key Insights

  • As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around -2.1% over the forecast period (2023-2030)
  • Based on Type segmentation, synthetic branded segment was predicted to show maximum market share in the year 2022, owing to high adoption of branded therapeutics in viral treatment.
  • Based on Application segmentation, HIV segment was the leading type in 2022, mainly due to increasing demand for antiretroviral therapy medications.
  • Based on Distribution Channel segmentation, hospital pharmacy was the leading type in 2022, mainly due to hospitalization treatment needs.
  • On the basis of region, North America was the leading revenue generator in 2022, owing to availability of technologically advanced production facilities.

Antiviral Drugs Market- Segmentation Analysis:

  • The Global Antiviral Drugs Market is segmented on the basis of Type, Application, Distribution Channel, and Region.
  • The market is divided into four categories based on Type: branded and generics. The branded segment dominates the market. The technology development, growing emphasis on novel therapeutics are likely to contribute to market growth.
  • The market is divided into five categories based on Application: HIV, hepatitis, herpes, influenza, and others. The HIV segment dominates the market and is likely to maintain its dominance during the forecast period. Antiviral drugs play crucial role in treatment of HIV viral infections with therapeutic medications.
  • The market is divided into three categories based on Distribution Channel: hospital pharmacy, retail pharmacy, and online pharmacy. The hospital pharmacy dominates the market and is likely to maintain its dominance during the forecast period. Online pharmacy is gaining more traction at fast pace with online e-commerce benefits.

Antiviral Drugs Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Antiviral Drugs Market- Competitive Landscape:

To increase their market share, businesses are engaging in strategic initiatives like joint ventures, mergers, acquisitions, clinical trials, and strategic agreements for the purpose of expanding their product line. Industry participants are also focusing on product releases for food allergies and global expansion to maintain their position in the global market. The worldwide antiviral drugs market has been further impacted by supportive FDA, U.S., and government collaborations. For instance, in December 2021, Merck collaborated with Ridgeback Biotherapeutics and established FDA approval for molnupiravir, an oral antiviral agent for backup use to treat low to high COVID-19.

Recent Developments:

In March 2022, Scripps Research, a research & technology and drug discovery organization, and AbbVie Inc. established a strategic collaboration to investigate novel drugs, to provide immediate treatments for COVID-19.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ANTIVIRAL DRUGS MARKET KEY PLAYERS

  • F. Hoffmann-La Roche Ltd.
  • GSK plc.
  • AbbVie, Inc.
  • Merck & Co., Inc.
  • Johnson & Johnson Services, Inc.
  • Bristol-Myers Squibb Company
  • Cipla Inc.
  • Ridgeback Biotherapeutics
  • Aurobindo Pharm
  • Dr. Reddy's Laboratories Ltd.
  • Zydus Pharmaceuticals
  • SIGA Technologies
  • Pfizer Inc.
  • NAVINTA LLC
  • Sun Pharma
  • Others

GLOBAL ANTIVIRAL DRUGS MARKET, BY TYPE

  • Branded
  • Generics

GLOBAL ANTIVIRAL DRUGS MARKET, BY APPLICATION

  • HIV
  • Hepatitis
  • Herpes
  • Influenza
  • Others

GLOBAL ANTIVIRAL DRUGS MARKET, BY DISTRIBUTION CHANNEL

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

GLOBAL ANTIVIRAL DRUGS MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Antiviral Drugs Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Antiviral Drugs Market Snippet by Type
    • 2.1.2. Antiviral Drugs Market Snippet by Application
    • 2.1.3. Antiviral Drugs Market Snippet by Distribution Channel
    • 2.1.4. Antiviral Drugs Market Snippet by Country
    • 2.1.5. Antiviral Drugs Market Snippet by Region
  • 2.2. Competitive Insights

3. Antiviral Drugs Key Market Trends

  • 3.1. Antiviral Drugs Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Antiviral Drugs Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Antiviral Drugs Market Opportunities
  • 3.4. Antiviral Drugs Market Future Trends

4. Antiviral Drugs Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Antiviral Drugs Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Antiviral Drugs Market Landscape

  • 6.1. Antiviral Drugs Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Antiviral Drugs Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2022 & 2030 (%)
    • 7.1.2. Branded
    • 7.1.3. Generics

8. Antiviral Drugs Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
    • 8.1.2. HIV
    • 8.1.3. Hepatitis
    • 8.1.4. Herpes
    • 8.1.5. Influenza
    • 8.1.6. Others

9. Antiviral Drugs Market - By Distribution Channel

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Distribution Channel, 2022 & 2030 (%)
    • 9.1.2. Hospital Pharmacies
    • 9.1.3. Retail Pharmacies
    • 9.1.4. Online Pharmacies

10. Antiviral Drugs Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Antiviral Drugs Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Antiviral Drugs Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Antiviral Drugs Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Antiviral Drugs Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Antiviral Drugs Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Antiviral Drugs Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. F. Hoffmann-La Roche Ltd.
    • 11.2.2. GSK plc.
    • 11.2.3. AbbVie, Inc.
    • 11.2.4. Merck & Co., Inc.
    • 11.2.5. Johnson & Johnson Services, Inc.
    • 11.2.6. Bristol-Myers Squibb Company
    • 11.2.7. Cipla Inc.
    • 11.2.8. Ridgeback Biotherapeutics
    • 11.2.9. Aurobindo Pharm
    • 11.2.10. Dr. Reddy's Laboratories Ltd.
    • 11.2.11. Zydus Pharmaceuticals
    • 11.2.12. SIGA Technologies
    • 11.2.13. Pfizer Inc.
    • 11.2.14. NAVINTA LLC
    • 11.2.15. Sun Pharma
    • 11.2.16. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us